Treatment
Treatment clinical trials
We’re tracking 8,479 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07009886Recruiting
Decision aid for advanced cancer patients considering more treatment
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
Houston, TexasAges 18 years+ - NCT07010237RecruitingPhase 2
Lower-dose immune therapy plus hetrombopag for older adults with severe aplastic anemia
This trial tests a milder version of immunosuppressive therapy combined with hetrombopag (a drug that helps bone marrow make blood cells) in people aged 65 years and older with severe aplastic anemia. The goal is to see if this approach is both safer and effective for older patients.
Tianjin, Tianjin MunicipalityAges 65 years+ - NCT07010263RecruitingPhase 3
AK112 for limited-stage small cell lung cancer after chemoradiation
This study tests a new drug called AK112 (a bispecific antibody that blocks both PD-1 and VEGF) as a consolidation treatment to help prevent your limited-stage small cell lung cancer from coming back after you've finished chemoradiation. It's for people whose cancer has not grown following concurrent chemotherapy and radiation.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07010484Recruiting
New imaging tests for polymyalgia rheumatica
This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.
AarhusAges 50 years+ - NCT07010978Recruiting
Testing recovery community centers for people on medication for opioid use disorder
This study tests whether recovery community centers (RCCs) help people who are taking medication for opioid use disorder (MOUD) stay in recovery. If you are on MOUD and live near a center that serves a Black community, you may be able to join.
Boston, MassachusettsAges 18 years+ - NCT07010939Recruiting
Side effects and quality of life after breast cancer treatment in China
This study looks at how local treatments like surgery, chemotherapy, radiation, hormone therapy, or targeted therapy affect your side effects and quality of life. Researchers want to learn from women with early-stage breast cancer to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07011186RecruitingPhase 1/Phase 2
TQB3909 and azacitidine for myeloid cancers
This trial tests a new oral drug, TQB3909, combined with a standard chemotherapy drug (azacitidine) for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The goal is to see if this combination is safe and effective.
Bengbu, AnhuiAges 18 years+ - NCT07011342Recruiting
Testing a new PET scan after focal treatment for prostate cancer
This trial tests a new type of PET scan to see how well it finds leftover cancer after you've had focal therapy (treatment to just part of the prostate) for intermediate-risk prostate cancer in the last 9 months.
Hackensack, New JerseyAges 18 years+ - NCT07011576RecruitingPhase 2
Fruquintinib plus FOLFIRI for second-line metastatic colorectal cancer
This trial tests a combination of two drugs, fruquintinib and FOLFIRI chemotherapy, as a second treatment option for people with metastatic colorectal cancer. It is designed for patients who have already received one prior treatment containing oxaliplatin, fluoropyrimidine, and bevacizumab.
Denver, ColoradoAges 18 years+ - NCT07011745RecruitingPhase 3
Testing KarXT for agitation in Alzheimer's disease
This trial tests if a new medicine, KarXT, can safely and effectively reduce agitation in people with Alzheimer's disease. It may help if you or your loved one experiences frequent agitation or aggression.
Chandler, ArizonaAges 55–90 - NCT07012031RecruitingPhase 1/Phase 2
Sotorasib and trastuzumab deruxtecan for KRAS G12C lung cancer
This trial tests a combination of two drugs, sotorasib and trastuzumab deruxtecan, for people with advanced or metastatic non-small cell lung cancer that has a KRAS G12C mutation. It may be an option if you've already had treatment with a KRAS G12C inhibitor, immunotherapy, and chemotherapy.
Sacramento, CaliforniaAges 18 years+ - NCT07012629RecruitingPhase 3
Preventing future strokes after silent brain infarcts
This study tests whether blood thinners and/or cholesterol-lowering medications can prevent future strokes in people who have small, silent brain infarctions found on MRI. If you've never had a stroke or TIA before, and are not already on similar medications, you may be a candidate.
AalborgAges 50 years+ - NCT07012720Recruiting
Comparing breast cancer treatments before surgery
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
Xi'an, ShaanxiAges 25–75 - NCT07012798RecruitingPhase 2
Sequential therapy for advanced liver cancer that may become removable
This trial tests a sequence of chemotherapy (FOLFOX), immunotherapy (durvalumab), targeted therapy (bevacizumab), and focused radiation to shrink liver tumors that are not removable now, with the goal of making them operable later.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07013292Recruiting
Omaveloxolone for swallowing issues in Friedreich's ataxia
This study looks at whether omaveloxolone (a medication) can help improve swallowing problems in people with Friedreich's ataxia. If you have been taking omaveloxolone for at least 6 months, your data may help researchers understand if it helps with swallowing.
Nice, Alpes MaritimesAges 16 years+ - NCT07014371Recruiting
Iron pills: every other day vs. daily
This trial tests whether taking iron pills every other day works as well as taking them every day. It is for people with iron deficiency anemia who have not used iron recently.
BangkokAges 20 years+ - NCT07015112Recruiting
Medication check for older adults with multiple conditions
This trial tests a team-based approach to review and improve medication use for older adults (65+) who have three or more chronic conditions and are staying in an intermediate care hospital. The goal is to make sure your medicines are as safe and effective as possible.
Barcelona, BarcelonaAges 65 years+ - NCT07015567Recruiting
CPTSD treatment for displaced people in Switzerland and Germany
This trial tests a treatment for complex post-traumatic stress disorder (CPTSD) in refugees and asylum seekers. It aims to help people who already completed part 1 of the study and were diagnosed with CPTSD.
Hamburg, Free and Hanseatic City of HamburgAges 17 years+ - NCT07016165RecruitingPhase 4
Comparing two antibiotics for fever with low white blood cells in children with blood cancer
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
Sleman, DI YogyakartaAges Up to 18 years - NCT07016620Recruiting
Laser therapy for BPH after prior treatment
This study tests if laser therapy can help men whose BPH symptoms came back after a previous less invasive procedure. It's a way to treat the blockage without more major surgery.
Cleveland, OhioAges 40 years+ - NCT07017699Recruiting
Deucravacitinib safety during pregnancy study
This study looks at how safe the medicine deucravacitinib (used for psoriasis) is during pregnancy. It compares pregnant women who took deucravacitinib to those who did not, to see if there are any effects on the baby.
La Jolla, CaliforniaAges Any age - NCT07017829RecruitingPhase 2
GT103 plus Keytruda for STK11 mutant lung cancer
This trial tests a new combination of two drugs—GT103 and Keytruda (pembrolizumab)—for people with advanced lung cancer that has a specific change in the STK11 gene. It is for those who have already tried Keytruda and their cancer progressed, but they might still benefit from continuing it.
Buffalo, New YorkAges 18 years+ - NCT07018037Recruiting
TTV levels during first immunotherapy for kidney cancer
This study looks at whether a virus called TTV (torque teno virus) in the blood can help predict how well immunotherapy works for advanced kidney cancer. If you have clear cell renal cell carcinoma that has spread and are about to start your first immunotherapy, you may be able to join.
Rome, RomeAges 18 years+ - NCT07018050RecruitingPhase 2
A study of a new combination for multiple myeloma
This study tests a new combination therapy for people with multiple myeloma that has returned or not responded to at least one prior treatment. The goal is to see if the combination (QLS32015 plus other drugs) can effectively control the cancer.
TianjinAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,479 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.